Supermax Corporation Berhad Past Earnings Performance
Past criteria checks 0/6
Supermax Berhad's earnings have been declining at an average annual rate of -23.7%, while the Medical Equipment industry saw earnings growing at 8% annually. Revenues have been declining at an average rate of 17.1% per year.
Key information
-23.7%
Earnings growth rate
-23.8%
EPS growth rate
| Medical Equipment Industry Growth | 12.3% |
| Revenue growth rate | -17.1% |
| Return on equity | -4.1% |
| Net Margin | -27.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Market Still Lacking Some Conviction On Supermax Corporation Berhad (KLSE:SUPERMX)
May 22
Is Supermax Corporation Berhad (KLSE:SUPERMX) Using Debt Sensibly?
Nov 20Is Supermax Corporation Berhad (KLSE:SUPERMX) Using Too Much Debt?
Apr 17Bearish: Analysts Just Cut Their Supermax Corporation Berhad (KLSE:SUPERMX) Revenue and EPS estimates
Feb 17Supermax Corporation Berhad (KLSE:SUPERMX) Could Easily Take On More Debt
Oct 15Why The 20% Return On Capital At Supermax Corporation Berhad (KLSE:SUPERMX) Should Have Your Attention
Sep 22These Analysts Just Made A Massive Downgrade To Their Supermax Corporation Berhad (KLSE:SUPERMX) EPS Forecasts
Aug 28Supermax Corporation Berhad Recorded A 7.1% Miss On Revenue: Analysts Are Revisiting Their Models
Aug 24Does Supermax Corporation Berhad (KLSE:SUPERMX) Have A Healthy Balance Sheet?
Jul 06Revenue & Expenses Breakdown
How Supermax Corporation Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 646 | -176 | 130 | 0 |
| 31 Mar 24 | 689 | -46 | 247 | 0 |
| 31 Dec 23 | 722 | -85 | 216 | 0 |
| 30 Sep 23 | 751 | -149 | 179 | 0 |
| 30 Jun 23 | 821 | -141 | 147 | 0 |
| 31 Mar 23 | 899 | -123 | 172 | 0 |
| 31 Dec 22 | 1,131 | -70 | 172 | 0 |
| 30 Sep 22 | 1,480 | 86 | 172 | 0 |
| 30 Jun 22 | 2,687 | 719 | 172 | 0 |
| 31 Mar 22 | 4,262 | 1,662 | 190 | 0 |
| 31 Dec 21 | 5,792 | 2,654 | 190 | 0 |
| 30 Sep 21 | 7,267 | 3,666 | 190 | 0 |
| 30 Jun 21 | 7,164 | 3,817 | 190 | 0 |
| 31 Mar 21 | 6,218 | 3,253 | 136 | 0 |
| 31 Dec 20 | 4,728 | 2,319 | 136 | 0 |
| 30 Sep 20 | 3,114 | 1,290 | 136 | 0 |
| 30 Jun 20 | 2,132 | 525 | 136 | 0 |
| 31 Mar 20 | 1,627 | 140 | 132 | 0 |
| 31 Dec 19 | 1,541 | 104 | 132 | 0 |
| 30 Sep 19 | 1,541 | 112 | 132 | 0 |
| 30 Jun 19 | 1,538 | 123 | 132 | 0 |
| 31 Mar 19 | 1,443 | 118 | 128 | 0 |
| 31 Dec 18 | 1,409 | 117 | 128 | 0 |
| 30 Sep 18 | 1,359 | 115 | 128 | 0 |
| 30 Jun 18 | 1,304 | 107 | 128 | 0 |
| 31 Mar 18 | 1,288 | 103 | 129 | 0 |
| 31 Dec 17 | 1,269 | 89 | 129 | 0 |
| 30 Sep 17 | 1,170 | 76 | 129 | 0 |
| 30 Jun 17 | 1,127 | 67 | 129 | 0 |
| 30 Jun 16 | 1,091 | 94 | 169 | 0 |
| 30 Sep 15 | 1,018 | 103 | 93 | 0 |
| 30 Jun 15 | 987 | 92 | 93 | 0 |
| 31 Mar 15 | 995 | 94 | 93 | 0 |
| 31 Dec 14 | 1,004 | 96 | 93 | 0 |
| 30 Sep 14 | 862 | 97 | 85 | 0 |
| 30 Jun 14 | 868 | 105 | 85 | 0 |
| 31 Mar 14 | 960 | 114 | 85 | 0 |
| 31 Dec 13 | 1,048 | 120 | 85 | 0 |
Quality Earnings: SUPERMX is currently unprofitable.
Growing Profit Margin: SUPERMX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SUPERMX is unprofitable, and losses have increased over the past 5 years at a rate of 23.7% per year.
Accelerating Growth: Unable to compare SUPERMX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SUPERMX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-1.4%).
Return on Equity
High ROE: SUPERMX has a negative Return on Equity (-4.1%), as it is currently unprofitable.